Ginkgo Bioworks Holdings (DNA) Intangibles (2020 - 2026)
Ginkgo Bioworks Holdings posted quarterly Intangibles of $48.9 million for Q1 2026, down 28.94% year-on-year from $68.8 million in Q1 2025, and down 8.64% on a QoQ basis from $53.5 million in Q4 2025.
Ginkgo Bioworks Holdings (DNA) has 7 years of Intangibles data on file, last reported at $48.9 million in Q1 2026.
- For the quarter ending Q1 2026, Intangibles fell 28.94% year-over-year to $48.9 million; the trailing twelve-month figure through Mar 2026 stood at $48.9 million (down 28.94% YoY), and the FY2025 full-year result was $53.5 million, down 26.24% from the prior year.
- Intangibles for Q1 2026 stood at $48.9 million, down from $53.5 million in the prior quarter.
- Across five years, Intangibles topped out at $111.0 million in Q4 2022 and bottomed at $20.8 million in Q1 2022.
- The 5-year median for Intangibles is $72.5 million (2024), against an average of $72.6 million.
- The widest annual swing landed in 2023, when Intangibles jumped 422.04%; it then dropped 28.94% in 2026.
- A 5-year view of Intangibles shows it stood at $111.0 million in 2022, then decreased by 25.49% to $82.7 million in 2023, then slipped by 12.37% to $72.5 million in 2024, then dropped by 26.24% to $53.5 million in 2025, then slipped by 8.64% to $48.9 million in 2026.
- The last three Intangibles figures came in at $48.9 million (Q1 2026), $53.5 million (Q4 2025), and $61.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 4.41 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 11,640.44 |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 30.30 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 418.50 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 1.29 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Ginkgo Bioworks Holdings | 542.03 Mn | 542.03 Mn | 16.38 Mn | 48.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 48.86 Mn |
| Dec 31, 2025 | 53.48 Mn |
| Sep 30, 2025 | 61.52 Mn |
| Jun 30, 2025 | 66.15 Mn |
| Mar 31, 2025 | 68.76 Mn |
| Dec 31, 2024 | 72.51 Mn |
| Sep 30, 2024 | 79.57 Mn |
| Jun 30, 2024 | 90.60 Mn |
| Mar 31, 2024 | 77.41 Mn |
| Dec 31, 2023 | 82.74 Mn |
| Sep 30, 2023 | 100.17 Mn |
| Jun 30, 2023 | 105.03 Mn |
| Mar 31, 2023 | 108.74 Mn |
| Dec 31, 2022 | 111.04 Mn |
| Sep 30, 2022 | 47.94 Mn |
| Jun 30, 2022 | 39.18 Mn |
| Mar 31, 2022 | 20.83 Mn |
| Dec 31, 2021 | 21.64 Mn |
| Sep 30, 2021 | 22.57 Mn |
| Dec 31, 2020 | 3.29 Mn |